Literature DB >> 23688409

Using Gd-EOB-DTPA-enhanced 3-T MRI for the differentiation of infiltrative hepatocellular carcinoma and focal confluent fibrosis in liver cirrhosis.

Yang Shin Park1, Chang Hee Lee, Baek Hui Kim, Jongmee Lee, Jae Woong Choi, Kyeong Ah Kim, Jeong Hwan Ahn, Cheol Min Park.   

Abstract

PURPOSE: The purpose of the study was to determine significant imaging features to differentiate between infiltrative hepatocellular carcinoma (HCC) and confluent fibrosis (CF) in liver cirrhosis using Gd-EOB-DTPA-enhanced 3-T magnetic resonance imaging.
MATERIAL AND METHODS: Nineteen infiltrative HCCs and eight CFs were included. We evaluated the difference in imaging findings and apparent diffusion coefficient (ADC) between the two entities. We compared T2-weighted image (WI) and hepatobiliary phase (HBP) in terms of the clarity of the lesion outer margin.
RESULTS: Seventeen infiltrative HCCs showed lobulated margin, while focal CFs showed either straight (n=3) or irregular margins (n=5) (P=.001). All infiltrative HCCs had intact or bulging contours, and all focal CFs showed capsular retraction (P=.001). Fourteen infiltrative HCCs and two focal CFs showed arterial enhancement (P=.035). The ADC of infiltrative HCCs was significantly lower than that of CFs (P=.001). Satellite nodules were noted in 10 infiltrative HCCs. In terms of outer margin clarity, infiltrative HCCs showed a more distinct margin on HBP than on T2-WI (P=.005), while these two sequences were not significantly different in focal CFs (P=1.000).
CONCLUSION: HBP improved the imaging characteristics of infiltrative HCC, allowing it to be distinguished from focal CF. Infiltrative HCC showed lower ADC values than focal CF. Lobular configuration, contour bulging, enhancement pattern, associated satellite nodules and portal vein thrombosis were still found to be highly suggestive MR findings for infiltrative HCC.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Confluent fibrosis; Gadoxetic acid; Gd-EOB-DTPA; Infiltrative hepatocellular carcinoma; Liver; MRI

Mesh:

Substances:

Year:  2013        PMID: 23688409     DOI: 10.1016/j.mri.2013.01.011

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  9 in total

Review 1.  Magnetic resonance imaging of the cirrhotic liver: An update.

Authors:  Agnes Watanabe; Miguel Ramalho; Mamdoh AlObaidy; Hye Jin Kim; Fernanda G Velloni; Richard C Semelka
Journal:  World J Hepatol       Date:  2015-03-27

Review 2.  Liver Masses: What Physicians Need to Know About Ordering and Interpreting Liver Imaging.

Authors:  Arman Sheybani; Ron C Gaba; R Peter Lokken; Senta M Berggruen; Winnie A Mar
Journal:  Curr Gastroenterol Rep       Date:  2017-10-18

Review 3.  Morphological, dynamic and functional characteristics of liver pseudolesions and benign lesions.

Authors:  Matteo Renzulli; Nicolò Brandi; Giulia Argalia; Stefano Brocchi; Andrea Farolfi; Stefano Fanti; Rita Golfieri
Journal:  Radiol Med       Date:  2022-01-13       Impact factor: 3.469

Review 4.  JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan.

Authors:  Masatoshi Kudo; Osamu Matsui; Namiki Izumi; Hiroko Iijima; Masumi Kadoya; Yasuharu Imai; Takuji Okusaka; Shiro Miyayama; Kaoru Tsuchiya; Kazuomi Ueshima; Atsushi Hiraoka; Masafumi Ikeda; Sadahisa Ogasawara; Tatsuya Yamashita; Tetsuya Minami; Koichiro Yamakado
Journal:  Liver Cancer       Date:  2014-10       Impact factor: 11.740

Review 5.  The MR imaging diagnosis of liver diseases using gadoxetic acid: emphasis on hepatobiliary phase.

Authors:  Woo Kyoung Jeong; Young Kon Kim; Kyoung Doo Song; Dongil Choi; Hyo Keun Lim
Journal:  Clin Mol Hepatol       Date:  2013-12-28

Review 6.  Atypical Appearance of Hepatocellular Carcinoma and Its Mimickers: How to Solve Challenging Cases Using Gadoxetic Acid-Enhanced Liver Magnetic Resonance Imaging.

Authors:  Jae Hyun Kim; Ijin Joo; Jeong Min Lee
Journal:  Korean J Radiol       Date:  2019-07       Impact factor: 3.500

7.  Infiltrative non-mass-like hepatocellular carcinoma initially presenting with isolated malignant portal vein thrombosis: A case report and review of the literature.

Authors:  Anıl Çolaklar; Namık Kemal Altınbaş
Journal:  J Ultrason       Date:  2020-03-31

Review 8.  Imaging findings of mimickers of hepatocellular carcinoma.

Authors:  Tae Kyoung Kim; Eunchae Lee; Hyun-Jung Jang
Journal:  Clin Mol Hepatol       Date:  2015-12-24

Review 9.  Pearls and pitfalls in magnetic resonance imaging of hepatocellular carcinoma.

Authors:  Jelena Djokic Kovac; Tamara Milovanovic; Vladimir Dugalic; Igor Dumic
Journal:  World J Gastroenterol       Date:  2020-05-07       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.